The addition of Cytosorb in patients on VA-ECMO improves urinary output and ICU survival.

Daniel Lovrić,Marijan Pašalić,Stefan Križanac,Karla Kovačić,Boško Skorić,Hrvoje Jurin,Davor Miličić,Vedran Premužić

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy（2023）

引用 0|浏览7

暂无评分

摘要

While a decrease in vasopressor doses was already associated with CytoSorb use, this is the first study showing an increase in urinary output and a trend towards better survival among patients on VA ECMO treated with CytoSorb.

查看译文

关键词

Cytosorb, hemoperfusion, survival, venoarterial ECMO

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要